The level of EGFR expression directly correlates with tumor grade, stage, and survival in human bladder cancer [25–27], thus serving as a novel prognostic marker to predict the chemo-responsiveness of patients with locally recurrent or metastatic MIBC [28, 29]. Here, EGFR is linked to urinary bladder cancer.